Simcere Pharmaceutical Group Limited (HKG:2096)
Hong Kong · Delayed Price · Currency is HKD 11.41
+0.42 (3.82%)
Sep 2, 2026, 9:40 AM HKT
HKG:2096 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 8,727 | 7,731 | 6,635 | 6,608 | 6,324 | 5,000 |
Revenue Growth | 12.87% | 16.52% | 0.41% | 4.49% | 26.49% | 10.89% |
Gross Profit Gross Profit Growth | 7,231 | 6,310 | 5,325 | 4,984 | 4,997 | 3,920 |
Operating Income Operating Income Growth | 1,747 | 1,417 | 1,124 | 710.84 | 606.34 | 233.33 |
Net Income Net Income Growth | 1,572 | 1,344 | 722 | 714.76 | 930.87 | 1,507 |
Earnings Per Share EPS Growth | 0.61 | 0.54 | 0.29 | 0.27 | 0.36 | 0.58 |
EPS Growth | 12.87% | 87.95% | 6.41% | -24.26% | -38.29% | 106.46% |
| Fiscal Year | TTM | FY 2025 | FY 2024 |
|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
Anti-oncology Business Anti-oncology Business Growth | 2,089 | 2,025 | 1,296 |
Other Pharmaceutical Business Other Pharmaceutical Business Growth | 6,738 | 5,801 | 5,382 |
Intersegment Elimination Intersegment Elimination Growth | -101.16 | -94.61 | -42.73 |
Total Total Growth | 8,727 | 7,731 | 6,635 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 4,027 | 3,578 | 1,963 | 2,018 | 2,623 | 2,183 |
Total Debt Total Debt Growth | 1,172 | 1,187 | 1,209 | 1,429 | 1,507 | 1,636 |
Net Cash (Debt) Net Cash Growth | 2,855 | 2,391 | 753.22 | 589.08 | 1,116 | 547.34 |
Net Cash Growth | 19.43% | 217.40% | 27.86% | -47.21% | 103.86% | - |
Net Cash Per Share Net Cash Per Share Growth | 1.12 | 0.96 | 0.30 | 0.23 | 0.43 | 0.21 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | - | 2,014 | 1,391 | 151.05 | 1,354 | -201.97 |
Capital Expenditures CapEx Growth | - | -349.33 | -369.98 | -483.18 | -342.82 | -209.49 |
Free Cash Flow Free Cash Flow Growth | - | 1,664 | 1,021 | -332.13 | 1,011 | -411.46 |
Free Cash Flow Growth | - | 62.97% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 82.86% | 81.61% | 80.25% | 75.43% | 79.01% | 78.40% |
Operating Margin | 20.02% | 18.33% | 16.94% | 10.76% | 9.59% | 4.67% |
Pretax Margin | 20.87% | 19.59% | 12.19% | 11.20% | 14.01% | 28.04% |
Profit Margin | 18.01% | 17.38% | 10.88% | 10.82% | 14.72% | 30.14% |
FCF Margin | - | 21.52% | 15.39% | -5.03% | 15.99% | -8.23% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.210 | 0.180 | 0.160 | 0.160 | 0.160 | 0.150 |
Dividend Per Share Growth | 18.36% | 12.50% | 0% | 0% | 6.67% | 0% |
Dividend Yield | 1.72% | 1.71% | 2.49% | 2.80% | 1.70% | 2.28% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 15.62 | 20.77 | 22.98 | 22.37 | 29.38 | 12.77 |
Forward PE | 12.12 | 16.58 | 14.35 | 12.11 | 29.04 | 26.63 |
P/FCF Ratio | - | 16.78 | 16.25 | - | 27.04 | - |
PS Ratio | 2.80 | 3.61 | 2.50 | 2.42 | 4.32 | 3.85 |